Established status epilepticus — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — IV levetiracetam
For established status epilepticus refractory to two doses of benzodiazepine, second-line agents include IV levetiracetam, IV phenytoin/fosphenytoin, or IV sodium valproate. The ESETT trial (referenced in RCH CPG) showed equivalent efficacy of these three agents. Levetiracetam is increasingly preferred due to its safety profile.
Reference: RCH Melbourne – 2024 – Seizures Acute Management CPG; Chamberlain JM et al – 2020 – ESETT Trial (Lancet)